CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
Fiberoptic bronchoscopyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02392182
NCT02392182N/ACompleted

Understanding the Lung Microbiome in HIV-Infected & HIV-Uninfected Individuals

University of Michigan·observational·Posted Mar 18, 2015·Updated Sep 16, 2016

In Brief

An observational study evaluating Fiberoptic bronchoscopy for Healthy Participants and 2 related conditions. Completed, enrolled 59 participants across 1 site.

Detailed Summary

In its original phase, this cohort study recruited subjects who were either HIV-positive or HIV-negative healthy controls, to analyze the community structure of the lung microbiome. Original recruitment was planned to occur both at the University of Michigan Medical Center and clinics, and at VA Ann Arbor Healthcare System. Enrollment for the original cohort is completed, and all current activity of this project is occurring at VA Ann Arbor, where both Veteran subjects and non-Veteran subjects are eligible to participate. This study is currently recruiting only healthy HIV-negative subjects. Participation, described below, involves a research bronchoscopy procedure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 18, 2015
Enrollment StartOct 1, 2009
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 11.3 years ago

Interventions

Fiberoptic bronchoscopyother

All subjects will undergo a research fiberoptic bronchoscopy under moderate conscious sedation. There is no randomization